Results 91 to 100 of about 743 (109)

Brivaracetam Disposition in Mild to Severe Hepatic Impairment

Journal of Clinical Pharmacology, 2013
Brivaracetam is a high-affinity synaptic vesicle protein 2A (SV2A) ligand in clinical development for epilepsy. This open-label, single-dose study evaluated brivaracetam disposition in participants with different degrees of hepatic impairment versus ...
Armel Stockis
exaly   +2 more sources

Effect of Brivaracetam (400 mg/Day) on the Pharmacokinetics and Pharmacodynamics of a Combination Oral Contraceptive in Healthy Women

Journal of Clinical Pharmacology, 2013
Brivaracetam is a high-affinity synaptic vesicle protein 2A ligand, in Phase III clinical development for epilepsy. This study assessed the effect of brivaracetam 400 mg/day on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive
Armel Stockis, Paul Rolan
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

A Review of the Drug−Drug Interactions of the Antiepileptic Drug Brivaracetam

Epilepsy Research, 2020
Barry Gidal, Brian D Moseley, Armel Stockis   +2 more
exaly  

Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience

Journal of Child Neurology, 2020
Sara McGuire, Darshan Lal, Ignacio Valencia   +2 more
exaly  

Anti-Convulsive and Anti-Epileptic Properties of Brivaracetam (Ucb 34714), a High-Affinity Ligand for the Synaptic Vesicle Protein, SV2A

British Journal of Pharmacology, 2008
Karine Leclercq, H Klitgaard
exaly  

Treatment of Refractory and Super-Refractory Status Epilepticus With Brivaracetam: A Cohort Study From Two German University Hospitals

Epilepsy and Behavior, 2017
Adam Strzelczyk, Laurent M Willems, Felix von Podewils   +2 more
exaly  

Binding Characteristics of Brivaracetam, a Selective, High Affinity SV2A Ligand in Rat, Mouse and Human Brain: Relationship to Anti-Convulsant Properties

European Journal of Pharmacology, 2011
Karine Leclercq, Michel Gillard, Bruno Fuks   +2 more
exaly  

Treatment With Brivaracetam in Children – The Experience of a Pediatric Epilepsy Center

Epilepsy and Behavior, 2019
Bruria Ben Zeev, Omer Bar Yosef, Michal Tzadok   +2 more
exaly  

Brivaracetam in the Treatment of Focal and Idiopathic Generalized Epilepsies and of Status Epilepticus

Expert Review of Clinical Pharmacology, 2016
Adam Strzelczyk, Sebastian Bauer, Laurent M Willems   +2 more
exaly  

Development of an Effective Novel Validated Stability-Indicating HPLC Method for the Resolution of Brivaracetam Stereoisomeric Impurities

Chirality, 2020
Vijayakumar Baksam
exaly